The Abingdon Health PLC (LON: ABDX) share price surged 31.4% as of 8:30 BST after announcing the launch of Salistick™, the first-ever saliva pregnancy test, in 298 Tesco stores and online at Tesco.com. The launch will make the saliva pregnancy test easily accessible to customers all across the United Kingdom.
YOUR CAPITAL IS AT RISK. 76% OF RETAIL CFD ACCOUNTS LOSE MONEY.
The launch of the Salistick™ pregnancy test will be focused on larger Tesco stores and Tesco.com online. The Tesco launch comes after the Salistick™ tests were launched in 400 Superdrug stores and online at Superdrug.com.
Top Broker Recommendation
- eToro Top stock trading platform with 0% commission – Read our Review
- Admiral Markets More than 4500 stocks & ETFs available – Read our Review
- BlackBull 26,000+ Shares, Options, ETFs, Bonds, and other underlying assets – Read our Review
- IG Top-tier regulation – Read our Review
- XTB UK regulated by the FCA – Read our Review
YOUR CAPITAL IS AT RISK. 76% OF RETAIL CFD ACCOUNTS LOSE MONEY
The Salistick™ pregnancy test offers women an improved user experience with high accuracy for early pregnancy detection. The revolutionary patented technology allows saliva to be used as a sample rather than the traditional urine sample.
The pregnancy test allows women to test whether they are pregnant at any time and place without worrying about providing a urine sample. Women can share the testing experience with their partners and loved ones since the test is based on saliva.
Abingdon Health is looking to capitalise on the growing market for pregnancy tests in the UK. Experts estimate that about 12.5 million pregnancy tests were conducted in the UK in 2022. The global pregnancy test kits market is valued at US$1.70 billion in 2022 and is expected to hit US$2.28 billion by 2028.
The company is the exclusive distributor of Salistick™ in the UK and Ireland on behalf of Salignostics Limited, an Israeli developer of innovative saliva-based diagnostics tests. Abingdon Health has also been providing Salignostics with contract development services to scale up the manufacturing of the Salistick™ test.
Chris Yates, Abingdon Health plc’s CEO, commented: “We are delighted to announce the launch of Salistick™ with Tesco online and rolled out across nearly 300 larger Tesco stores. This novel technology provides women with an enhanced user experience, offering the ability to test anywhere, anytime, and for the testing experience to be shared with a partner and other loved ones. We continue to explore distribution opportunities for Salistick™ both in the UK and internationally, and we look forward to launching the Salistick™ dual pack in due course.”
Abingdon Health (ABDX) share price.
The Abingdon Health (ABDX) share price surged 31.43% to trade at 11.50p, from Monday’s closing price of 8.75p.
YOUR CAPITAL IS AT RISK. 76% OF RETAIL CFD ACCOUNTS LOSE MONEY.